He was accepted by Trump: in the USA, permission to treat COVID-19 with hydroxychloroquine was revoked

The U.S. Food and Drug Administration (FDA) has revoked its authorization to use hydroxychloroquine and chloroquine to treat COVID-19 in emergency cases. CNN.

Photo: Shutterstock

President Donald Trump often praised hydroxychloroquine, and he claimed to be taking it himself.

After examining the current study of affordable drugs, the FDA found that these drugs do not meet the “statutory criteria” for emergency use because they are unlikely to be effective in treating COVID-19 based on the latest scientific evidence, the agency said on its website on Monday. June 15th.

“FDA has concluded that, based on this new information and other data discussed in the attached memorandum, it is no longer reasonable to believe that oral formulations of HCQ and CQ may be effective in treating COVID-19, and there is no reason to believe that The known and potential benefits of these products outweigh their known and potential risks,” FDA Chief Scientist Denise Hinton wrote in a letter to Gary Disbor of the Biomedical Research and Development Authority (BARDA).

Hydroxychloroquine and chloroquine have been associated with serious heart problems, as well as other side effects in patients with COVID-19.

“Accordingly, the FDA is revoking the emergency use authorization of HCQ and CQ for the treatment of COVID-19,” Hinton said in the letter, using abbreviations for hydroxychloroquine and chloroquine. “As of this writing, the FDA has no longer authorized oral HCQ and CQ medications for the treatment of COVID-19.”

Doctors may continue to legally prescribe medications in other cases, as with any medication approved for other conditions. The FDA’s approval for emergency use of hydroxychloroquine and chloroquine was narrow; it applied only to hospitalized patients with COVID-19 and only to drugs donated to the National Strategic Reserve.

On the subject: What is hydroxychloroquine and does it protect against coronavirus

In an open letter published at the end of May, FDA Commissioner Dr. Stephen Khan defended the agency’s decision to grant permission.

“This decision was based on an assessment of the criteria and scientific evidence available at the time. We continue to review the data on hydroxychloroquine and chloroquine, and in the future we will identify these products based on available data, including ongoing clinical studies,” he said.

Emergency authorization, or EUA, has made it easier to distribute nationally distributed tablets to patients with coronavirus.

Khan added in the letter that "we also knew that it was important to ensure a stable supply of drugs for patients with lupus and rheumatoid arthritis, given the increased demand."

In a May CNN interview, Khan also acknowledged the political climate surrounding the drugs, but said: “I support our decisions because I think they are based on science and data and we will continue to re-evaluate.”

On May 15, WHO officials said they were still considering the use of hydroxychloroquine in their clinical study of treatment options for COVID-19 with the participation of many countries. The organization temporarily suspended the trial in May due to concerns about the safety of the drug and to review its own data, but resumed the program in early June.

On the subject: Some drink purifiers, others deny the threat: how people die because of fakes about coronavirus

Trump has been a proponent of the combination of hydroxychloroquine and the azithromycin antibiotic to treat COVID-19. He mentioned these drugs dozens of times, despite scientists asking them to let researchers know if the treatment worked, and said he was taking hydroxychloroquine to prevent coronavirus infection.

Despite warnings from health experts, retail sales of drugs that have been produced for decades have risen sharply in recent weeks amid growing public attention to drugs.

Read also on ForumDaily:

Over $ 1 million: Seattle resident cured of COVID-19 and shocked by medical bill

Antibody cocktail: US trials of new COVID-19 drug

In 19 states, an increase in the number of cases of infection with coronavirus has been recorded: what will happen next

Surprise Accounts: What You Need to Know About COVID-19 Medical Insurance and Treatment

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis.